Get App Open
In App
Lending
Lending
Open App
you are here:
Success
Alert
Please select a Day.
Info

Glenmark Pharma Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

63/100
2,051.90
61.00 (3.06%)

As on 05 Sep, 2025 | 03:58

Open Trading A/c
Day Range
1990.90
2055.20
L H
52 Week Range
1275.50
2284.80
L H
Volume
977,419
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
208 2051.95 2056.45 54
12 2051.70 2056.80 74
122 2051.65 2056.95 12
12 2049.85 2057.00 10
1 2048.00 2057.80 1
0 Total Total 0
Bid / Ask
0.00 / 0.00
63/100
2,056.35
65.75 (3.30%)

As on 05 Sep, 2025 | 04:01

Open Trading A/c
Day Range
1990.60
2056.35
L H
52 Week Range
1274.70
2286.15
L H
Volume
18,367
*
i

* BSE Market Depth (05 Sep 2025)

BUY SELL
QTY PRICE PRICE QTY
208 2051.95 2056.45 54
12 2051.70 2056.80 74
122 2051.65 2056.95 12
12 2049.85 2057.00 10
1 2048.00 2057.80 1
0 Total Total 0
Bid / Ask
0.00 / 0.00
63/100
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
Bid / Ask
/
63/100
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
Bid / Ask
/
NSE
MC Essentials
65% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 1,990.90
          Previous Close 1,990.90
          Volume 977,419.00
          Value (Lacs) 20,055.66
            VWAP 2,043.51
          Beta
          Mkt Cap (Rs. Cr.) 57,905
          High 2,055.20
          Low 1,990.90
          UC Limit 2,189.90
          LC Limit 1,791.90
          52 Week High 2,284.80
          52 Week Low 1,275.50
          Face Value 1.00
          All Time High 2,284.80
          All Time Low 18.75
          20D Avg Volume 714,858
          20D Avg Delivery(%) 49.11
          Book Value Per Share 299.28
          Dividend Yield 0.12
          TTM EPS See historical trend 26.71 (+157.48% YoY)
          TTM PE See historical trend 76.82 (High PE)
          P/B See historical trend 6.86 (High P/B)
          Sector PE 39.40

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          63/100
          Average Financial Strength, High Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 10.19% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 46.65% in Jun 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 17 years Glenmark Pharma has given positive returns in September.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          September 11.56% (2023) 6.00% -15.42% (2019) -5.50% 0.59%

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling Glenmark

          What's your call on Glenmark today?

          Read 1 investor views

          BUY SELL HOLD

          Broker Research

          18 Aug, 2025

          Motilal Oswal

          Reco Price 1974.40 Target Price 2400
          19 Aug, 2025

          ICICI Securities

          Reco Price 1945.90 Target Price 1570
          18 Jul, 2025

          ICICI Securities

          Reco Price 2223.05 Target Price 1620
          11 Jul, 2025

          Motilal Oswal

          Reco Price 2181.55 Target Price 2430
          26 May, 2025

          Motilal Oswal

          Reco Price 1389.20 Target Price 1690
          18 Feb, 2025

          KRChoksey

          Reco Price 1377.65 Target Price 1768

          Deals

          25 Mar, 2025

          Integrated Core Strategies (asia) Pte. Ltd.

          Qty 264465 Price 1492.65 % Traded 0.09
          25 Mar, 2025

          Ubs Ag

          Qty 264465 Price 1492.65 % Traded 0.09
          23 Jan, 2025

          Ubs Ag

          Qty 671394 Price 1510 % Traded 0.24
          23 Jan, 2025

          Ubs Principal Capital Asia Limited

          Qty 671394 Price 1510 % Traded 0.24

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          11 Jul, 2025

          Graviton Research Capital Llp

          Qty 1510591 Price 2171.67 % Traded 0.53
          11 Jul, 2025

          Graviton Research Capital Llp

          Qty 1510591 Price 2173.31 % Traded 0.53

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Glenmark 2,051.90 3.06 57,904.78 76.82 6.86 11.83 20.03 1,047 13,321 0.25
          Sun Pharma 1,593.60 0.71 382,358.02 36.86 5.53 15.13 -12.75 10,980 52,578 0.03
          Divis Labs 6,009.00 -2.03 159,520.07 69.17 11.63 14.63 17.34 2,191 9,360 0.00
          Cipla 1,553.40 -1.55 125,476.52 23.27 4.42 16.90 -4.57 5,291 27,547 0.00
          Torrent Pharma 3,579.10 -0.56 121,133.01 60.51 16.14 25.17 3.97 1,911 11,516 0.40

          About the Company

          Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.
          {"success":1,"data":{"address":{"address1":"B\/2, Mahalaxmi Chambers,","address2":"22, Bhulabhai Desai Road,,","city":"Mumbai","state":"Maharashtra","pincode":"400026","telephone1":"022-40189999","telephone2":"022-40189879","fax1":"022-40189986","fax2":"","email":"complianceofficer@glenmarkpharma.com","web":"http:\/\/www.glenmarkpharma.com"},"management":[{"name":"Glenn Saldanha","designation":"Chairman & Managing Director"},{"name":"Cherylann Pinto","designation":"Executive Director - Corporate Affairs"},{"name":"V S Mani","designation":"Executive Director & Global CFO"},{"name":"B E Saldanha","designation":"Non Executive Director"},{"name":"Saira Ramasastry","designation":"Ind. Non-Executive Director"}],"registrars":{"name":"KFIN Technologies Pvt. Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"Yes"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"Yes"}],"details":{"bseId":"532296","nseId":"GLENMARK","series":"EQ","isinid":"INE935A01035"}}}
          • Registered Office

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • Glenn Saldanha

              Chairman & Managing Director

            • Cherylann Pinto

              Executive Director - Corporate Affairs

            • V S Mani

              Executive Director & Global CFO

            • B E Saldanha

              Non Executive Director

            • Saira Ramasastry

              Ind. Non-Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              Yes

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              Yes

          • Details

            • BSE:

              532296

            • NSE:

              GLENMARK

            • Series

              EQ

            • ISIN

              INE935A01035